NervGen Pharma Corp.

NGEN:TSX.V; NGENF:OTCQX

Last:
Change: Change(%):
Volume: Open:
High: Low:
52Wk High: 52Wk Low:

NervGen is a publicly traded biotech company dedicated to discovering and developing treatments for patients suffering from medical conditions related to nerve damage.